SCHEMBL31616338

SCHEMBL31616338

COc1ccccc1NC(=O)N[C@@H](C)c1cccc2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ TRPV1 Q8NER1 2/20 0.60
▸ LPAR1 Q92633 1/20 0.60
▸ ALDH1A1 P00352 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ ANPEP P15144 1/20 0.53
▸ GAA P10253 1/20 0.52
▸ EPHX2 P34913 2/20 0.50
▸ MAPT P10636 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ MAPK14 Q16539 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31616415 1.00 MEN1 (0.62) MEN1KMT2ATRPV1LPAR1ALDH1A1
SCHEMBL31616442 1.00 MEN1 (0.62) MEN1KMT2ATRPV1LPAR1ALDH1A1
SCHEMBL31616463 0.86 LTC4S (0.57) MEN1KMT2ALPAR1ALDH1A1KDM4E
SCHEMBL31616376 0.86 LTC4S (0.57) MEN1KMT2ALPAR1ALDH1A1KDM4E
SCHEMBL31616450 0.86 LTC4S (0.57) MEN1KMT2ALPAR1ALDH1A1KDM4E
SCHEMBL18120560 0.81 MEN1 (0.75) MEN1KMT2ALPAR1ALDH1A1KDM4E
SCHEMBL24575927 0.81 EPHX2 (0.64) MEN1KMT2ATRPV1GAAEPHX2
SCHEMBL31616452 0.80 KMT2A (0.53) MEN1KMT2ATRPV1ALDH1A1SMN1; SMN2
SCHEMBL31616465 0.80 KMT2A (0.53) MEN1KMT2ATRPV1ALDH1A1SMN1; SMN2
SCHEMBL31616458 0.80 KMT2A (0.53) MEN1KMT2ATRPV1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025122121-A2 COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND THE METHOD OF OBTAINING THESE COMPOUNDS HACETTEPE UNIVERSITESI REKTORLUK (TR) 2025-06-12 — — WO claimed
WO-2025122121-A2 COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND THE METHOD OF OBTAINING THESE COMPOUNDS HACETTEPE UNIVERSITESI REKTORLUK (TR) 2025-06-12 — — WO disclosed
Send feedback